Targeted Genetics, Columbus Children’s Research Institute, International AIDS Vaccine Initiative deal

The parties extended a 2000 deal to develop an AIDS vaccine using TGEN’s Adeno-Associated Viral Vectors (AAV) to deliver HIV genes (see BioCentury, Feb. 22, 2000). As extended, TGEN will receive an ad...